Among the 46 genes selected most often in either of the risk prediction models, we found genes that were previously identified as important players in lung cancer development, e.g. SAA2 [18], HAS2 [46–48] or TGM3 [49–52], in line with the current literature. Here, HAS2 is linked to lung carcinoma.